CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• How Can I Increase My Viral Titers And Improve The Percentage Of Full AAVs?

  Explore various strategies to enhance viral titer and increase the percentage of full AAV capsids, like modifications to transfection reagents, cell lines, media, procedures, and more.

• Rapid Production Of Assay Ready Cells For GPCR Drug Discovery

  Accelerate drug discovery by leveraging transiently transfected assay-ready cells. This method improves assay sensitivity and reduces variability for GPCRs.

• Why RWD Strategy Can't Wait With Price, Value And Evidence Pressures Everywhere

  Overcome pricing pressures and reimbursement delays by integrating real-world evidence early in development to align clinical outcomes with payer demands and accelerate patient access.

• Understanding EndoCleave's Role In Viral Vector Manufacturing

  Achieving high-quality viral vectors demands rigorous control over contaminants. Learn about enzymatic approaches to significantly reduce nucleic acid impurities in your manufacturing processes.

• Levers To Optimize The IVT Reaction For Increased mRNA Yield

  Mastering IVT yield requires balancing magnesium and nucleotide ratios. Learn how specific buffers and pyrophosphatase optimize mRNA synthesis for scalable, high-quality therapeutic production.

• A Journey To Produce MSC-Derived Cell Therapies From Isolation To Large-Scale

  Drive successful MSC therapy development by optimizing isolation methods, surface chemistry, and closed-system expansion technologies to ensure cellular stability and commercial scalability.

• Enhancing Novel Developability Through Automated MS Analytics

  Growing biotherapeutic complexity demands MS workflows that can unify diverse datasets. Learn how automated approaches enhance data quality, streamline analysis, and support faster development.

• AAV Capsid Analysis With Single Particle Mass Photometry

  Accurate AAV capsid ratios are critical to gene therapy efficacy. See how mass photometry delivers faster, lower-cost E/F analysis with single-particle resolution.

• Transforming Clinical Trial Management

  See how Vestigo^® can transform your study management — streamline workflows, strengthen compliance, and eliminate inefficiencies by adopting a smarter, digital-first approach today.

• Select The Best Analyte: A Guide To Effective Mycoplasma Testing

  As you build a Mycoplasma testing strategy to ensure drug safety, there are three analyte types to choose from: live Mycoplasma, RNA, and genomic DNA, each offering distinct advantages.